Notices. Notice of registration
351 words·~2 min read·
/register/2016/04/18/2016-08843A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Manufacturer of Controlled Substances Registration: Cody Laboratories, Inc. ACTION: Notice of registration. SUMMARY: Cody Laboratories, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration
(DEA)grants Cody Laboratories, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated December 4, 2015, and published in the **Federal Register** on December 10, 2015, 80 FR 76709, Cody Laboratories, Inc., 601 Yellowstone Avenue, Cody, Wyoming 82414 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cody Laboratories, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Schedule Dihydromorphine
(9145)I Amphetamine
(1100)II Methamphetamine
(1105)II Methylphenidate
(1724)II Amobarbital
(2125)II Pentobarbital
(2270)II Secobarbital
(2315)II 4-Anilino-N-phenethyl-4-piperidine
(8333)II Phenylacetone
(8501)II Cocaine
(9041)II Codeine
(9050)II Dihydrocodeine
(9120)II Oxycodone
(9143)II Hydromorphone
(9150)II Diphenoxylate
(9170)II Ecgonine
(9180)II Hydrocodone
(9193)II Meperidine
(9230)II Methadone
(9250)II Methadone intermediate
(9254)II Morphine
(9300)II Thebaine
(9333)II Oxymorphone
(9652)II Alfentanil
(9737)II Remifentanil
(9739)II Sufentanil
(9740)II Tapentadol
(9780)II Fentanyl
(9801)II The company plans to manufacture the listed controlled substances in bulk for sale to its customers. Dated: April 11, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016-08843 Filed 4-15-16; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources